Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
T Cell
100%
Infection
96%
Infectious Disease
90%
Virus
81%
Epstein Barr Virus
79%
Measles Virus
70%
Human T-Lymphotropic Virus 1
66%
Natural Killer Cell
62%
In Vitro
60%
Viral Disease
46%
Wart Virus
40%
Cotton Rat
38%
Immune Response
29%
B Cell
27%
Oncolytic Herpes Virus
26%
Viral Replication
26%
Squamous Cell
26%
Replication
24%
Human T Cell Leukemia Virus
24%
Gene Expression
24%
Human Immunodeficiency Virus
23%
Cytokine
22%
interferon
21%
Herpesviridae
20%
Virotherapy
20%
Neck
20%
Virus Type
19%
Oncolytic Virus
19%
Human Alphaherpesvirus 1
19%
Ribonucleic Acid
19%
Cell Line
19%
Tumor Cell
19%
Immunotherapy
19%
Lymphocyte
18%
Susceptibility
18%
Human T-Lymphotropic Virus 2
18%
Interleukin 2
17%
Immune System
17%
Mouse Model
17%
Macrophage
16%
T-Helper Cell
15%
Adoptive Immunity
15%
Cytotoxic T-Cell
15%
Human Papillomavirus Type 16
14%
Promoter Region
14%
Heat Shock
14%
Retrovirus
14%
Wild Type
13%
Programmed Cell Death
13%
Glycoprotein
13%
Inflammation
13%
Human Respiratory Syncytial Virus
13%
Cytotoxicity
13%
Cytomegalovirus
13%
Phosphotransferase
13%
Kinase
13%
Antigen
12%
DNA Virus
12%
Acquired Immune Deficiency Syndrome
11%
Lung
11%
Antibody Titer
11%
Virus Genome
11%
Virus Nucleocapsid
11%
Encephalitis
11%
Cytotoxic T Cell
10%
Innate Immune System
10%
Interleukin 6
10%
Xenograft
10%
Leukocyte
9%
Peripheral Blood Mononuclear Cell
9%
Maternal Antibody
9%
Cell Transformation
9%
Lymphoproliferative Disorders
9%
Neutralizing Antibody
9%
Central Nervous System
9%
Immunocompetent Cell
9%
Prevalence
9%
Peptides
9%
Secretion (Process)
8%
Proinflammatory Cytokine
8%
Cellular Stress Response
8%
Carboxy Terminal Sequence
8%
Amino Acid
8%
Myeloid
8%
Protein Expression
8%
Multiple Myeloma
8%
Chronic Stress
8%
Immunosuppressive Drug
8%
Mental Stress
8%
phosphorylation
8%
Monoclonal Antibody
8%
Lymphoma Cell
8%
Herpes Simplex Virus
8%
Immunomodulation
8%
Signal Transduction
8%
Rat Model
8%
Dendritic Cell
8%
Vesiculovirus
8%
Viral Load
8%
Minimum Inhibitory Concentration
8%
Keyphrases
Human T-cell Leukemia Virus Type 1 (HTLV-1)
87%
Epstein-Barr Virus
77%
Measles Virus
61%
Natural Killer Cells
52%
Virus
49%
Tumor
48%
T Cells
46%
Human Papillomavirus
42%
Head-and-neck Cancer
35%
Cotton Rat
34%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
31%
Oncolytic Herpes Simplex Virus (oHSV)
28%
Head-and-neck
27%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
24%
Viral
23%
Oncolytic Virus
23%
Immune Response
22%
HPV16
19%
Protein Arginine Methyltransferase 5 (PRMT5)
18%
Mantle Cell Lymphoma
18%
Mouse Model
18%
Cutaneous T-cell Lymphoma
18%
Virus Type
18%
Overall Survival
17%
Tumor Cells
17%
Gene Expression
17%
Glioblastoma
16%
Measles Infection
16%
Interferon-α (IFN-α)
16%
Immune Function
16%
Oncolytic
15%
Non-Hodgkin Lymphoma
15%
Virus Replication
15%
Herpes Simplex Virus Type 1 (HSV-1)
14%
Sigmodon Hispidus
14%
Nasopharyngeal Carcinoma
14%
Inflammation
13%
Older Adults
13%
Immune System
13%
Interleukin-2
13%
Interleukin-6
12%
Lymphoma
12%
Nucleoside Triphosphate Diphosphohydrolase
12%
Burkitt Lymphoma
12%
Glioma
12%
Lymphoproliferative Disorders
12%
Mycosis Fungoides
12%
Clinical Trials
12%
HTLV-2
12%
B Cells
12%
Virus-specific
12%
Chronic Lymphocytic Leukemia
11%
Chemotherapy
11%
Chronic Stress
11%
Herpesvirus
11%
United States
11%
Oral Human Papillomavirus (HPV) Infection
11%
Adult T-cell Leukemia/lymphoma
11%
In Cancer
11%
Respiratory Syncytial Virus
11%
Heat Shock Protein 70 (HSP70)
11%
Lymphocytes
11%
95% Confidence Interval
11%
Hybrid Cells
10%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
10%
Virotherapy
10%
Apoptosis
10%
Cellular Immune Response
10%
Viral Replication
10%
Psychological Stress
10%
Stress-induced
10%
Neuroimmunoendocrinology
10%
AIDS/HIV
10%
Recombinant
9%
Progression-free Survival
9%
Infected Cells
9%
Immune Dysregulation
9%
Burkitt
9%
T Cell Response
9%
Retrovirus
9%
Acute Myeloid Leukemia
9%
Virus-induced
9%
Rituximab
9%
Lymphoma Cells
9%
Cancer Cells
9%
Radiotherapy
9%
Antibody Titer
9%
Tumor Microenvironment
9%
Overexpression
9%
Macrophages
9%
Virus Genome
9%
Risk Factors
8%
Maternal Antibodies
8%
Multiple Myeloma
8%
Phosphorylation
8%
Nivolumab
8%
Cytomegalovirus
8%
Caregivers
8%
Malignancy
8%
Heat Shock Proteins
8%
Medicine and Dentistry
Diseases
42%
Wart Virus
37%
Malignant Neoplasm
35%
Neck
34%
Head and Neck Cancer
33%
Epstein Barr Virus
33%
Neoplasm
31%
Cancer
31%
Overall Survival
27%
Tumor
24%
Oropharynx Carcinoma
23%
Free Tissue Graft
23%
Radiation Therapy
23%
Oral
23%
Squamous Cell Carcinoma
21%
T Cell
21%
Infection
19%
Virus
19%
Non-Hodgkin Lymphoma
18%
Oncology
17%
Chemotherapy
17%
Human T-Lymphotropic Virus 1
16%
Oral Cavity
16%
Ganglioglioma
14%
Clinical Trial
14%
Head and Neck Squamous Cell Carcinoma
14%
Human Immunodeficiency Virus
13%
Cutaneous T Cell Lymphoma
13%
Mycosis fungoides
13%
Adult T-Cell Leukemia/Lymphoma
12%
Papillomavirus Infection
11%
B Cell
11%
Progression Free Survival
11%
Glioblastoma
11%
Burkitt's Lymphoma
10%
Human Papillomavirus Type 16
10%
Carcinogenesis
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Oropharynx Squamous Cell Carcinoma
10%
Oncolytic Herpes Virus
10%
T-Cell Lymphoma
10%
P16
10%
In Vitro
9%
Pediatrics
9%
Mantle Cell Lymphoma
9%
Immunotherapy
9%
Diffuse Large B-Cell Lymphoma
9%
Robot-Assisted Surgery
9%
Recurrent Disease
9%
B-Cell Lymphoma
9%
Lymphoproliferative Disease
9%
Acquired Immune Deficiency Syndrome
9%
Oropharynx
8%
Rituximab
8%
Oncolytic Virus
8%
Nivolumab
8%
Prevalence
8%
Lymphocyte
8%
Hazard Ratio
8%
Xenograft
8%
Leukemia
7%
Malignant Peripheral Nerve Sheath Tumor
7%
Nasopharynx Carcinoma
7%
Oral Cancer
7%
Tumor Cell
7%
Virus DNA
7%
Cyclophosphamide
7%
Metastatic Carcinoma
6%
Odds Ratio
6%
Solid Malignant Neoplasm
6%
Pediatric Cancer
6%
Pathogenesis
6%
Targeted Therapy
6%
Biopsy Technique
6%
Virus Replication
6%
Arm
6%
Quality of Life
6%
Chemoradiotherapy
6%
Genetics
5%
Base
5%
Human Alphaherpesvirus 1
5%
Messenger RNA
5%
Biological Marker
5%
Serositis
5%
Cohort Effect
5%
Morbidity
5%
Central Nervous System
5%
Protein Arginine Methyltransferase 5
5%
Sodium Fluoride
5%
Cutaneous Lymphoma
5%
Rhabdomyosarcoma
5%
Cytokine
5%
Cell Line
5%
Adverse Event
5%
Adjuvant Therapy
5%
Cisplatin
5%
Oncolytic Virotherapy
5%
Cancer Therapy
5%
Natural Killer Cell
5%
Skull Base
5%